Trending
Recently Published
All Articles
The race to mine the moon is on – and it urgently needs some clear international rules31.12.2025There are billions of dollars in it for companies able to kickstart mining operations, even if such returns are still years away.- From Representative to Business visionary: Private issue Victories25.09.2023Progressing from being a representative to turning into a business visionary is a huge jump that implies facing challenges, seeking after interests, and
- Study shows no clear link between low-fat dairy and dementia risk17.12.2025Low-fat dairy and other dairy foods showed no clear association.
- We may have less control over how long we live than previously thought06.04.2026Subscribe to The Post Most newsletter for the most important and interesting stories from The Washington Post. Uri Alon was long puzzled by a textbook statistic: Longevity, the thinking went, was about 20 percent in our genes. “That makes you think what’s the rest of the 80 percent: Is it the lifestyle? Why should we study genes for lifespan if it’s not that important? It kind of bothered me,” said Alon, a physicist turned systems biologist at the Weizmann Institute of Science in Israel. Alon us
- Under pressure at home, Belgium's leader treads a tight rope with EU partners over funds for Ukraine18.12.2025For decades, Belgium has been at the beating heart of the European Union. The headquarters of the 27-nation bloc’s main institutions and NATO are based there. EU leaders meet in the capital Brussels at least four times a year.
- How food assistance programs can feed families and nourish their dignity25.11.2025Free food may fill your stomach, but it doesn’t always satisfy the desire to feel fully human.
- Opening Innovativeness: Moving Thoughts and Tasks01.01.1Innovativeness is an unfathomable wellspring of development and motivation that exists inside every one of us. Whether you're a craftsman, a researcher, a business visionary, or anybody enthusiastically for creative mind, religion
- US FDA approves Kura-Kyowa's blood cancer therapy13.11.2025By Kamal Choudhury and Christy Santhosh (Reuters) -The U. Food and Drug Administration on Thursday approved Kura Oncology and Japanese partner Kyowa Kirin's once-daily pill, Komzifti, to treat a rare form of blood cancer that has returned or stopped responding to treatment.
